NEW
Font size
WorksheetsQuestion Set 3
Total questions: 10
Worksheet time: 3mins
Lung cancer is 2 nd common cancer in Vietnam. Please advise what is the number of new
patients acquired lung cancer per year in Vietnam according to GlobalCAN 2018?
23, 667
24, 667
25,667
ALK is one of rare mutation in lung cancer. The percentage of ALK mutation in lung
cancer patients is?
1% - 3%
3% - 5%
5% - 7%
Alecensa (Alectinib) increases our belief about curable therapy in lung cancer. Please
share how long of PFS this brand offered to lung cancer, ALK (+)?
PFS > 33.8 months
PFS > 34.8 months
PFS > 36.8 months
Tecentriq (Atezolizumab) recovers natural body immune system to kill cancer cells
through PL-L1 pathway. Please recall what was the key benefit of Tecentriq in 2 nd line
treatment of lung cancer?
OS # 13.8 months
OS # 14.8 months
OS # 15.8 months
In the near future, Roche Vietnam would offer more effective therapies in lung cancer
patients including of:
2L Tecentriq, Alecensa, A + T and T plus A
1L Tecentriq, Alecensa, A + T (Avastin + Tarceva), T + A (Tecentriq + Avastin)
Alecensa, A + T and T plus A
How long of PFS ‘A + T’ (Avastin plus Tarceva) offered in lung cancer, EGFR (+)?
PFS 15.9 months
PFS 16.9 months
PFS 17.9 month
Colorectal cancer (CRC) is 5 th common cancer in Vietnam. Please advise what is the
number of new patients acquired CRC per year in Vietnam according to GlobalCAN
2018?
14,733
15,733
16,733
Avastin (Bevacizumab) is an anti-angiogenesis therapy which was approved for mCRC
treatment since 2004. Please recall what was the key benefit of this brand in mCRC?
OS > 20 months regardless RAS, Chemo & Age
PFS > 20 months regardless RAS, Chemo & Age
DFS > 20 months regardless RAS, Chemo & Age
How you know about liver cancer in Vietnam according to GlobalCAN 2018?
1st common cancer
3rd common cancer
4th common cancer
In future, which brand can extend our leadership in Hepatocellular carcinoma (HCC)?
Avastin
Tecentriq
The combination of Tecentriq plus Avastin
